Cargando…

Editorial: Translational Approaches for Targeting Cardiovascular Complications of Diabetes

Detalles Bibliográficos
Autores principales:	Sharma, Arpeeta, De Blasio, Miles J., Tate, Mitchel, Ritchie, Rebecca H., Murray, Andrew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635766/ https://www.ncbi.nlm.nih.gov/pubmed/34867431 http://dx.doi.org/10.3389/fphar.2021.799020

Ejemplares similares

Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
por: Sharma, Arpeeta, et al.
Publicado: (2018)

Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes
por: Ng, Hooi Hooi, et al.
Publicado: (2018)

Recent novel approaches to limit oxidative stress and inflammation in diabetic complications
por: Pickering, Raelene J, et al.
Publicado: (2018)

Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic Cardiomyopathy
por: Tate, Mitchel, et al.
Publicado: (2021)

Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy – current and future perspectives
por: Prakoso, Darnel, et al.
Publicado: (2021)

The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction
por: Sharma, Arpeeta, et al.
Publicado: (2017)

Cardiovascular characterisation of a novel mouse model that combines hypertension and diabetes co-morbidities
por: Sharma, Arpeeta, et al.
Publicado: (2023)

Targeting Endothelial Dysfunction in Vascular Complications Associated with Diabetes
por: Sharma, Arpeeta, et al.
Publicado: (2012)

Editorial: Targeting inflammation to prevent complications in stroke
por: Varela, Lourdes M., et al.
Publicado: (2023)

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
por: Valencia, Inés, et al.
Publicado: (2020)

Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
por: Tate, Mitchel, et al.
Publicado: (2019)

Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
por: Tate, Mitchel, et al.
Publicado: (2021)

Editorial: Computational and Experimental Approaches in Multi-target Pharmacology
por: Anastasio, Thomas J.
Publicado: (2017)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Editorial: Pharmacoepidemiology in Diabetes Mellitus and its Complications: Focus on Response to Medications
por: Mohammadi Jouabadi, Soroush, et al.
Publicado: (2022)

Editorial: Women in translational pharmacology: 2021
por: Vengeliene, Valentina, et al.
Publicado: (2023)

Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
por: Chernyak, Boris V., et al.
Publicado: (2021)

Editorial: Cardiovascular remodeling
por: Yang, Yan, et al.
Publicado: (2023)

Editorial: Natural products based management of neurological disorders: Mechanistic insight and translational informatics approach
por: Kumar, Suresh, et al.
Publicado: (2023)

Editorial: Myocardial Remodeling: Mechanisms and Translational Implications
por: Roncalli, Jerome, et al.
Publicado: (2022)

Editorial: Translating nanomedicines for anti-cancer treatment
por: Siram, Karthik, et al.
Publicado: (2023)

Editorial: Targeting pumps, channels and transporters for the treatments of vascular, cardiovascular and kidney diseases
por: Zhang, Jinwei, et al.
Publicado: (2023)

IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus
por: Peiró, Concepción, et al.
Publicado: (2017)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Novel therapeutic approaches to target drug resistant tumors
por: Riganti, Chiara, et al.
Publicado: (2023)

Editorial: Novel pharmacological approaches targeting mitochondrial dysfunction in diseases
por: Uddin, Md. Jamal, et al.
Publicado: (2022)

Editorial: Alzheimer’s Disease: Original Mechanisms and Translational Impact
por: Mancuso, Cesare, et al.
Publicado: (2020)

Editorial: Verification of Animal Pain Models by Reverse Translation
por: Caudle, Robert M., et al.
Publicado: (2021)

The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart
por: Tate, Mitchel, et al.
Publicado: (2019)

Editorial: Mechanisms Underlying Diabetes-Associated Damage in Target Tissues
por: Suarez-Alvarez, Beatriz, et al.
Publicado: (2022)

Editorial: Translational Research and Drug Repurposing for Non-Communicable Diseases (NCDs)
por: Akindele, Abidemi J., et al.
Publicado: (2022)

Editorial: Emerging mechanisms in cardiovascular disease
por: Yalcin, Huseyin C., et al.
Publicado: (2023)

Sex differences in risk of cardiovascular events and mortality with sodium glucose co-transporter-2 inhibitors versus glucagon-like peptide 1 receptor agonists in Australians with type 2 diabetes: a population-based cohort study
por: Sharma, Abhipree, et al.
Publicado: (2023)

Editorial: Interplays and Functions of Gaseous Mediators: From Underlying Mechanisms to Therapeutic Approaches in Cardiovascular Diseases
por: Brancaleone, Vincenzo, et al.
Publicado: (2022)

Editorial: Cardio-Protection and Heart Repair: New Drugs, Targets and Approaches
por: Zagidullin, Naufal, et al.
Publicado: (2021)

Editorial: Advance in translational research of preterm birth and related pregnancy
por: Xie, Han, et al.
Publicado: (2022)

Editorial: Adipose Tissue in the Cardiovascular Homeostasis and Disease
por: Butcher, Joshua T., et al.
Publicado: (2021)

Editorial: Circadian biology, cardiovascular function and disease
por: Chong, Nelson, et al.
Publicado: (2023)

Editorial: Natural products targeting oxidative stress and cell death: Treatment potential in metabolic and cardiovascular diseases
por: Kosuru, Ramoji, et al.
Publicado: (2023)

Testing the Translational Power of the Zebrafish: An Interspecies Analysis of Responses to Cardiovascular Drugs
por: Margiotta-Casaluci, Luigi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m9qbnqb0rfq3a79l5igjscodrf